Insider trading

Period: 120 months Stock: KROS Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

76 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

76 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

76 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

76 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
76 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
76 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

76 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Jul 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$1.38M 46,034 at 30.00
32.6%
13 Jul 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$57.48K 1,916 at 30.00
2.0%
11 May 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 5×
$222.05K 5,300 at 41.90
5.8%
11 Apr 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 4×
$332.70K 5,300 at 62.77
5.8%
6 Apr 2022
Rovaldi Christopher Chief Operating Officer
Sold, plan not stated
$112.32K 1,728 at 65.00
100%
Sold half or more
4 Apr 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$477.00K 7,950 at 60.00
8.5%
1 Apr 2022
Rovaldi Christopher Chief Operating Officer
Sold, plan not stated 5×
$49.68K 864 at 57.49
100%
Sold half or more
11 Mar 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 3×
$141.45K 2,650 at 53.38
3.0%
11 Feb 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 3×
$137.96K 2,650 at 52.06
3.0%
11 Jan 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 3×
$142.45K 2,650 at 53.75
3.0%
5 Jan 2022
Knowles Julius Director · indirect
Sold, plan not stated 6×
$234.99K 4,034 at 58.25
1.7%
5 Jan 2022
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$159.00K 2,650 at 60.00
3.0%
4 Jan 2022
Knowles Julius Director · indirect
Sold, plan not stated 10×
$1.15M 20,062 at 57.55
7.9%
3 Jan 2022
Knowles Julius Director · indirect
Sold, plan not stated 8×
$1.37M 23,555 at 58.01
8.9%
15 Dec 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$36.75K 735 at 50.00
0.9%
13 Dec 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 3×
$96.81K 1,915 at 50.55
2.2%
2 Dec 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$1.36M 25,338 at 53.57
9.2%
1 Dec 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$1.22M 22,313 at 54.68
7.9%
11 Nov 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 2×
$316.06K 5,300 at 59.63
5.8%
10 Nov 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$954.00K 15,900 at 60.00
15.6%
4 Nov 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$530.00K 10,600 at 50.00
11.0%
3 Nov 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$669.78K 15,967 at 41.95
5.6%
2 Nov 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$334.15K 7,881 at 42.40
2.8%
1 Nov 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$1.00M 23,803 at 42.15
7.8%
20 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$156.09K 4,082 at 38.24
1.4%
19 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$172.35K 4,516 at 38.16
1.5%
18 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$519.71K 13,786 at 37.70
4.5%
15 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$321.05K 8,198 at 39.16
2.7%
14 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$175.89K 4,383 at 40.13
1.4%
5 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$104.76K 2,617 at 40.03
0.9%
4 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$150.06K 3,746 at 40.06
1.2%
1 Oct 2021
Knowles Julius Director · indirect
Sold, plan not stated 2×
$253.93K 6,323 at 40.16
2.0%
27 Sep 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$3.92M 95,302 at 41.17
23.6%
2 Jul 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$984.57K 23,818 at 41.34
6.4%
1 Jul 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$983.79K 23,834 at 41.28
6.3%
11 Jun 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 3×
$135.09K 2,650 at 50.98
3.3%
11 Jun 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated 2×
$50.99K 1,000 at 50.99
100%
Sold half or more
7 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 12×
$638.45K 12,796 at 49.89
3.4%
4 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$314.16K 6,619 at 47.46
1.8%
3 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$378.73K 7,895 at 47.97
2.1%
2 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$562.14K 11,529 at 48.76
3.0%
1 Jun 2021
Knowles Julius Director · indirect
Sold, plan not stated 8×
$462.69K 8,812 at 52.51
2.3%
11 May 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated
$132.50K 2,650 at 50.00
3.6%
11 May 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated
$50.15K 1,000 at 50.15
100%
Sold half or more
4 May 2021
Knowles Julius Director · indirect
Sold, plan not stated 4×
$152.86K 2,835 at 53.92
0.7%
3 May 2021
Knowles Julius Director · indirect
Sold, plan not stated 10×
$2.58M 44,816 at 57.48
10.4%
12 Apr 2021
Lachey Jennifer Chief Scientific Officer
Sold, plan not stated 4×
$318.03K 5,300 at 60.00
6.9%
12 Apr 2021
Ordonez Claudia Chief Medical Officer
Sold, plan not stated 3×
$59.93K 1,000 at 59.93
100%
Sold half or more
6 Apr 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$546.84K 9,298 at 58.81
2.3%
5 Apr 2021
Knowles Julius Director · indirect
Sold, plan not stated 6×
$1.63M 27,151 at 60.07
6.3%
Showing 1–50 of 76. Page 1 of 2 Older →